S

Secretome Therapeutics

HealthUnited States

Secretome Therapeutics is focused on developing regenerative cardiac therapies, particularly targeting conditions like Duchenne muscular dystrophy associated cardiomyopathy. The company aims to restore and regenerate cardiac function through innovative cellular therapies, with recent funding set to advance their clinical trials and manufacturing capabilities.

$30M · Series AVisit website ↗

🏆 Featured in Datapile’s Q2 2026 USA Funding Report

Read the Q2 2026 USA report →
Add this badge to your site
Featured in Datapile’s Q2 2026 USA Funding Report
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 USA Funding Report</a>

Funding history

  1. $30MSeries A2026-05-28
    Source: news.google.com ↗

Investors in Secretome Therapeutics

Backers from this company's tracked funding rounds.

  • RA Capital Management

More Health companies

Recently funded startups in the same category.

Related on Datapile